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As a psoriatic lesion deve~ops at sites of p~eviou~ly uninvo~ved 
skin, cytokines and theII subsequent mductlOn of ~ano~s 
adhesion molecules may play important pathophYSIOlogIC 
roles. To further define the cytokine network in psoriasis, 
biopsies we~e o.b~ained fr?m bot~ l~sional skin and lesion-
free skin of mdlvlduals wIth psonaSlS and compared to nor-
mal skin biopsies from control subjects. Each biopsy was 
analyzed usin~ polymera~e .chain reaction for. expreSSIOn of 
cytokines and llnmunostammg to detect adhesIOn molecules. 
The results indicate that psoriatic lesions have a type 1 cyto-
kine profile (i.e., interleukin[ILJ-2, interferon[IFN]-Y, and 
rumor necrosis factor[TNF]-a), without a significant com-
ponent of type 2 cytokines (i.~., IL-4, IL-S, a~d IL-IO) ac-
companied by aberrant expreSSIOn of endothehal cellleu~o­
cyte adhesion molecule (ELAM)-l and vascular cell adheslOn 
P soriasis is multifactorial in. etiology, yet recent findings support a central role for T cells in its pathogel!esis. Histologic hallmarks include epidermal hyperplaSia as-sociated with cellular infiltrate of lymphocytes and monocytejmacrophages. Immunohistologic analysis 
. dicates that T cells of the CD4+ type predominate in the dermal 
:£iltrate [1,2]. Furthermore, production of interieukin(IL)-2 and 
interferon(IFN)-Y in lesions indicates an active local cell-mediated 
immune response (3]. Clearance after allogeneic bone marrow 
transplantation, and the efficacy of cyclosporine A ~nd anti-C:D.4 
therapy further implicate T cells in the pathogeneSIs of psonasls 
~-~. . . . . 
Division of CD4+ T cells mto dlStlllCt functional subsets (THl 
and T H2) based upon cytokine profiles is a major advance in our 
understanding of immune responses [9]. This has most clearly been 
shown in murine models of inflammation in which there is a di-
chotomy between cell-mediated and humoral immune responses. 
T 1 cells produce IL-2 and IFN-y, resulting in T -cell proliferation 
a:d macrophage activation. In contrast, T H2 cells produce IL-4, 
IL-S, and IL-10, cytokines that augment antibody respon~es. Recent 
studies indicate that similar patterns can be correlated With human 
skin disease. In leprosy, "type 1" (i.e., IL-2 and IFN-y) cytokines are 
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molecule (VCAM)-l on dermal endothelial cells, and 
ICAM-l on epidermal keratinocytes. Four of five lesion-free 
biopsies from psoriatic patients had prominent cytokine 
mRNA expression compared with skin from normal donors 
(particularly TNF-a, IL-la, IL-lfJ, w ith lesser increases in 
IFN-y and granulocyte/macrophage colony-stimulating fac-
tor [GM-CSF]), which was accompanied by aberrant adhe-
sion molecule expression in the same four samples. We con-
clude that a particular T-cell population producing type 1 
cytokines accumulates in psoriatic lesions. In addition, clini-
cally lesion-free skin is characterized by increased levels of 
various cytokine mRNAs, and aberrant adhesion molecule 
expression i~ ~oth derr~al and epidermal compartments. Key 
words: psonaSlS/cytokmes/adhesiol1 molecules.] Invest Der-
mato/t01 :701 - 705, 1993 
elevated in cell-mediated immune reactions, whereas in contrast 
"type 2" (i.e., IL-4, IL-5, and IL-10) cytokines are prominent when 
antibody responses are strong and cell-mediated immune responses 
~re sup.pressed [1~:11]. Type 2 cytokine patterns are also prominent 
111 atopIC dermatltls and late-phase allergic reactions [1 2]. 
The present study was undertaken to determine the dominant 
cytokine pattern in skin lesions of psoriasis lesions versus non-le-
sional skin as compared with skin from normal donors. This was 
accomplished by using a strategy that combined simultaneous as-
sessm~nt of both mRNA cytokine levels as well as specific translated 
adheSIOn protems under the regulation of these cytokines in the 
same tissue biopsy material. The expression of adhesion molecules 
i~ skin provides inherent evidence concerning the presence of spe-
Cific cytokme patterns. We focused on endothelial cell leukocyte 
adheSIOn molecule (ELAM)-1, vascular cell adhesion molecule 
(VCAM)-1 '. and intercellu.lar adhesion molecule (ICAM)-l because 
of th.e !?rOWI~lg bod~ of eVidence supporting their important role in 
medlatl11g differential cutaneous T-cell and monocyte trafficking 
[13,14]. 
MATERIALS AND METHODS 
Specimen Source T.wo different sets of skin biopsy samples were ob-
tamed .from adult partICipants. In the first set, six biopsies of wltreated 
psonatlc.plaques were obtamed from five psoriatic patients, and fi ve biopsies 
from leSIOn-free skin were obtained from the same five patients; they were 
processed .for both mRNA and immunostaining. Also, three biopsies of 
normal skm from two healthy volunteers without any illness were used as 
controls. In the second set of biopsies, an additional four lesional, five lesion-
free and four normal skin biopsies were obtained solely to extend our im-
munohistochemical results . After obtaining informed consent of volunteers 
and the approval of the University of Michigan Human Subjects Commit-
0022-202Xj93jS06.00 Copyright © 1993 by The Society for Investigative Dermatology, Inc. 
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tee, all skin specimens were obtained by 6-mm punch biopsy and embedded 
ill gum tragacanth (Sigma C hemical Co~pany, St. LOUIS, MO). ln addltlon, 
punch biopsies from untreated patients with lIchen planus (n. = 2), tubercu-
loid leprosy (n = 1), and lepromatous leprosy (n = 1) were I11cluded 111 the 
study. 
RNA Isolation and cDNA Synthesis We have recently reported our 
success in isolating RNA and performing polymerase chain reaction (PCR) 
on small skin biopsy specimens [11]. Briefly, fifty 5-jlm-thick ctyostat sec-
tions were isolated from skin biopsy specimens and lysed III guamdl11111m 
isothiocyanate. RNA was isolated by phenol chloroform extraction and 
ethanol precipitation. Messenger RN A was reverse transcrIbed Illto cD N A 
in the presence of oligo-d(T) (Pharmacia LKB ,. Piscataway, NJ), 0:5 mM 
deoxynucleotide triphosphates (dNTPs), and aVian myeloblastOSIs ViruS re-
verse transcriptase (GIBCO BRL, Gaithersburg, MD) at 42 'C for 1 h. 
PCR PCR was performed as previously described [15]. Briefly, the PCR 
reaction mixture contained 2.5 mM MgCl 2 , 0.2 mM dNTP, 25 pM 5' and 
3' oligonucleotide primers, and 2.5 U Taqyolymerase (Promega Corp., 
Madison, WI) . Samples were then amplIfied In a DNA Thermocycler (Per-
kin Elmer, San Diego, CAl for 35 cycles. Each cycle consisted of denatura-
tion at 94'C for 1 min and annealing/extension at 55 ' C (for IL-2 and 
IFN-y) or 65'C for 2 min (all other cytokines). An aliquot ofPCR pro~uct 
was then electrophoresed on 2% agarose gels a~d Visualized by e~h ldIUl~ 
bromide staining. The sequences of cytokl11e speCific pnmer paITS, 5 and 3 , 
were as follows. IL-la, TGAGCAATGTAAATACAAC and GAGAAAC-
CATCCTGGAGGAA; IL-lP, GACACATGGGATAACGAGGC and 
ACGCAGGACAGGTACAGATT; IL-2, ACTCACCAGGATGCTCA-
CAT and AGGTAATCCATCTGTTCAGA; IL-4, CTTCCCCCTCT-
GTTCTTCCT and TTCCTGTCGAGCCGTTTCAG; IL-5, ATGAG-
GATGCTTCTGCATTTG and TCAACTTTCTATTATCCACTCGG-
TGTTCATTAC; IL-10, ATGCCCCAAGCTGAGAACCAAGACCCA 
and TCTCAAGGGGCTGGGTCAGCTATCCCA; IFN-y, AGTTATA-
TCTTGGCTTTTCA and ACCGAATAATTAGTCAGCTT; TNFa, 
T CT CGAACCCCGAGTGACAA and TATCTCTCAGCTCCACA-
CCA; LT, CCTCACACCTTCAGCTGCCC and GAGAAACCATCCT-
GGAGGAA; GM-CSF, TGGCTGCAGAGCCTGCTGCTC and TCAC-
TCCTGGACTGGCTCCC; p-actin, GTGGGGCGCCCCAGGCACCA 
and CTCCTTAATGTCACGCACGATTTC; CD30, CTGGACCTGG-
GAAAACGCATC and GTACTGAGCATCATCTCGATC. 
·To ensure detection of amplified cDNA rather than genomic DNA, 
primers were selected to span introns. The oligonucl.eotide primers and 
conditions used for PCR resulted in amplification of a Single product of the 
expected size after electrophoresis. As an internal control for PCR template 
variabi li ty, p-actin, which is relatively invariant in all cell types, was used to. 
normalize for equivalent total cel lular mRNA in PCR reactions. CD30 
chain, which is present exclusively in T cells, was used to normalize cDNA 
for message produced predominantly by T cel ls. Five se rial dilutions of 
individual cDNAs were amplified using p-actin or CD30 oligonucleotide 
primers and were accompanied by concomitant decrease of amplified prod-
ucts. Normalization of samples for PCR was achieved by selecting cDNA 
concentrations that yield equivalent quantities of p-actin or CD30 products. 
It was important that the selected concentration of cDNA was within the 
linear range of amplification to prevent reagents from becoming rate limit-
ing, which would make small differences in product concentrations difficult 
to discern. 
Radioactive Hybridization of PCR Product To verify cytokine 
mRNAs, PCR products were transferred to Hybond-N nylon membranes 
(Amersham, Corp., Arlington Heights, IL) and probed with a labeled oli-
gonucleotide complementary to sequences internal to the se9~ences recog-
nized by the PCR amplIfication primers. Blots were hybndlzed for 4 h, 
washed for 5 min with 2 X sodium citrate solution and 0.1 % sodium dode-
cyl sulfate followed by 0.2 X sodium citrate and 0.5% sodium dodecyl sulfate 
at ambient temperature, and exposed to x-ray film at non-sa turatll1g condi-
tions. Sequences of the oligonucleotide probes were IL-la, TCAGGAT-
GAA TTCGTA TTTGATGAT; IL-lP, AGCTTTTTTGCTGTGAGTC-




IFN-y, ATTTGGCTCTGCATTATTTTTCTGT; LT, TCTGCTTGC-
TGGGGTCTCCAA TGAG; p-actin, CTGCTGACCG AGGCCCCCCT-
GAACCCC;CD30GCCGACACACAAGCTCTGTTGAGGA. 
The autoradiographic findings of the cytokine results were ranked to 
relate the expression of cytokines with the immunostaining for adhes ion 
molecules. A rank of 0 was given for samples that did not emit a visible band 
and a rank of 4 was scored for samples that radiated a maximal visible band. 
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Ranks of 1, 2, or 3 were scored for samples that produced 25, 50, or 75% of 
maximal band intensity, respectively. 
Validiry of peR A number of cO l1 trols were employed to ensure accurate 
comparisons of the different samples studied. PCR analysis of tenfold seri-
ally diluted plasm ids containing IL-2, IL-4, IFN-y, IL-6, IL-10, and tumor 
necrosis factor(TNF) -a cDNAs with visualization by ethidium bromide 
staining indicated that our PCR procedure was sensi tive to the order of 
102 - 10' copes for each cytokine [11]. Furthermore, the intensity of the PCR 
product increased accord ing to the number of copies of starting plasmid to at 
least 109 copies. These PCR products were transferred to nylon membrane, 
probed, and quantified by radioanalytic imaging. There was a 10g-lll1ear 
correlation between the number of starting copies and the quantity ofPCR 
products throughout the range investigated. These results indicated that our 
PCR conditions could provide meaningful comparison of the small amounts 
of cytokine mRNAs expressed in skin lesions. 
Upon PCR amplification of serial dilutions of sample cDNAs, a concomi-
tant decrease in the PCR product was observed. Similarly, varying the num-
ber of PCR cycles did not change the relative differences between samples. 
These studies indicate that our PCR conditions were not within the plateau 
phase of amplification. Mixing of cD NAs from different patients did not 
inhibit or augment PCR amplification, indicating that cDNAs do not di-
rectly alter PCR efficiency. Each experiment included a positive control 
cDNA template (phorobol myristatc acetate + ionomycin-treated PBMC) 
and a negative control (RNA that had not been reverse transcribed or a 
sample of buffer alone). The latter control did not yield PCR product, 
confirming the absence of ex traneous cON A or PCR product contanllnatUlg 
the samples. In addition, we routinely used extensive precautions to avoid 
PCR artifact including assembling reactions in laminar flow hoods, use of 
aliquoted reagents, pipettes dedicated for assembling PCR reactions, and 
aerosol-resistant tips (Continental Lab Products, La Jolla, CAl. 
Itnmunohistochemical Staining Cryostat sections were air-dried, ace-
tone fixed, incubated in primary mouse monoclonal antibodies (MoAbs), 
and followed by avidin-biotin as previously described [16]. Mouse MoAbs 
used in this stlldy included detection of ELAM-l (BB- l, obtained from Dr. 
R. Lobb, Biogen Inc. , Boston, MA) , VCAM-l (4B9, obtained from Dr. John 
I-Iarlan, University of Seattle, W A) , and ICAM-1 (RR1/1, obtained from 
Dr. T. Springer, Harvard University, Boston, MA) . 3-amino 9-ethylcarba-
zole was used as the chromogen and counterstained with hematoxylin. The 
extent and intensity of staining were semiquantitatively assessed as previ-
ously described [16]. Briefly, endothelial cell reaction was scored on a 0-6 
scale with the following val ues: 0, negative reactivity; 2, weak reactivity 
detected on less than five vessels per section; 4, moderate reactivity detecta-
ble on six to ten vessels per sec tion; 6, strong reactivity easi ly detectable in 
more than ten vessels per section. Keratinocyte ICAM- l expression was 
scored by: 0, no epidermal staining; I , < 25% of all epidermal keratinocytes 
per section were positive; 2, 25 - 50%; 3, 50- 75%; 4, > 75%. 
RESULTS 
Psoriatic Skin is Characterized by a Type 1 Cytokine Profile 
To determine the T-cell cytokine pattern that typifies the local 
immune response in active, untreated psoriasis, we used PCR to 
compare levels of cytokine mRNA expression in the lesions from 
four individuals with psoriasis, two individuals with lichen planus, 
and two individuals with leprosy. The leprosy biopsy specimens, 
one tuberculoid leprosy, and one lepromatous leprosy, provide e..x-
amples of the "type 1" and "type 2" cytokine patterns, respectively, 
as previously reported [15]. Biopsy specimens oflichen planus, rep-
resenting another chronic inflammatory skin disorder characterized 
by epidermal thickening and mononuclear cell infiltration predom-
inate ly ofT cell s, were included for comparison. To compensate for 
minor differences in the amount of T-cell cDNA between speci-
mens, cD NAs w ere standardized by PCR to yie ld equivalent quan-
tities of CD3b product (data not shown). We found mRNA level 
for IFN-y and Iymphotoxin in psoriasis lesions approaching level 
found in tuberculoid leprosy (Fig 1 and Table 1) . There were subtle 
differences in the levels of IL-2 mRNA between psoriatic lesions, 
lichen planus, and leprosy. We also found that mRNAs for IL-4 
IL-5, and IL-lO, comparable to a "type 2" cytokine pattern, w ere 
weakly expressed or absent in psoriatic les ions as compared to their 
relative abundance in the lepromatous leprosy lesion. These find-
ings indicated that psoriatic les ions contain cell s characteristic of the 
"type 1" cytokine pattern. 












p'gure L PCR analysis of cytokine mRNAs in skin disease lesions. Com-~risons were made betwe~n lesional skin biopsy specimens collected from 
p tients with psonaSlS (patIents 1,2,3, 4a), ltchen planus, tuberculOId lep-~~Sy (T), and lepromatous l epro~y (L). cDNAs were synthesized from 
RNAs isolated from cryostat sections of bIOpsy specImens and ampltfied by 
;CR using specific oligonucleotide primers for IL-2, IFN-y, IL-4, IL-S, 
IL-10, and lymphotoxin (LT). Initially, individual cDNA concentrations for 
PCR were normalized to yield equivalent quantities of CD30. PCR was 
erformed using appropriate quantities of cON A.' products :,ere transfer~ed ;0 nylon membranes, probed with an internal oltgonucleottde labeled WIth 
121', and exposed to x-ray film. 
The cytokine Profile in Psoriatic, Symptomless, and Nor-
mal Skin PCR was also used to compare cytokine mR~A ex-
ression in biopsy specimens of lesional and lesion-free sbn from 
Patients with psoriasis (Fig. 2 and Table I). PCR analyses of cyto-
hues elaborated by T cells were normalized to the CD3J product as 
mentioned above (data not shown) . Levels of mRNA for IL-2 and 
IFN-Y were elevated compared to lesion-.free and normal skin. In 
one symptomless skin sample of a psonatlc patient, IFN-y was 
strongly expressed. IL-4 mRNA was absent from all bu.t one o.f the 
rnples studied. IL-IO mRNA was present in two of SIX psonatlc, 
:'0 of five lesion-free, and one of three normal skin samples, with 
no particular distr~bution. ~hes~ results indi~ate that expression of 
cycokine mRNAs 111 pso~latic leSIOns was dlst111Ct from symptomless 
psoriatic and normal skin. . 
Message for cytokines elaborated by a variety of cell types, 111-
eluding macrophages and .keratin~cytes, was d~t~rmined af~er nor-
malization of cDNAs to Yield eqUivalent quantities of f/-act111 PCR 
product (data not shown). We found elevated levels o.fTN~-O' and 
lL- lP rnRNA in psoriatic lesions compared to that 111 leSIOn-free 
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skin and normal skin (Fig 3). TNF-O' and IL-lfl mRNA levels were 
also greater in lesion-free skin of psoriasis than in normal skin. 
Levels of mRNA for IL-IO' and GM-CSF were not different be-
tween lesional psoriatic, lesion-free psoriatic, and normal skin. 
Lesional Psoriatic Skin Contains Strong Expression of 
ELAM-l.' VCAM-l, and ICAM-l Active psoriatic plaques are 
charactenzed by marked acanthosis, mononuclear cell infiltration, 
and diffuse and strong expression of ELAM-l by venular endothe-
lial cells. The most striking ELAM-l staining included post-capil-
lary venule~ of the supe.rfi.cial vascular plexus with weaker reactivity 
of lym~hatlc endothelIUm (data not shown) . Similarly, VCAM-1 
expreSS1~n (data not shown) was strongly and diffusely positive on 
post-capIll~ry venules and on penvascular dendritic cells as previ-
ously descr~bed [16J. ICAM-1 .was more widely expressed (data not 
shown): be111g strongly and dIffusely present on endothelial cells, 
infiltrat111g mononuclear cells, and keratinocytes in the epidermis, 
as previously described [17J . 
Lesion-Free Skin Also Has Aberrant Adhesion Molecule Ex-
pression Compared to Normal Skin Compared to psoriatic 
lesional skin, the overall expression of ELAM-l, VCAM-l, and 
ICAM-l was considerably more focal and less intense in lesion-free 
skin. ~owever, in sever~ l lesion-free specimens (Table I), distinc-
tively illcreased expreSSIOn of these adhesion molecules was seen 
compar~d to normal skin. Detectable ELAM-l expression in the 
postcapillary venules was observed in eight of ten lesion-free sam-
p.les and in only one of six normal skin samples. VCAM-l expres-
SIOn was also det~ctable in seven of ten lesion-free samples com-
pared to ~ero of SIX normal skin biopsies. ICAM-l expression was 
detected 111 four of ten lesion-free samples and was not seen in any of 
the normal skin samples. 
Correlation Between Cytokine mRNA Results and Adhe-
sion Molecule Expression In general there was excellent corre-
lation between the cytokine mRNA levels detected by PCR, and the 
aberrant expression of adhesion molecules both on vascular dermal 
endothelial cells and epidermal keratinocytes (Table I) . ELAM-l 
and VCAM-l are both inducible by TNF-O' and IL-1 [18,19J , 
whereas kerat1110cyte ICAM-1 is inducible by IFN-y and TNF-O' 
[17J. Thus, in all lesional psoriatic biopsies in which there was 
diffuse and strong ELAM-l and VCAM-1 expression, there was 
co,:comitant.detection .0f TNF-0' and IL-l mRNAs. Similarly, the 
leslOl1al psonatlc bIOpSies all had elevated ICAM-l expression and 
detectable IFN-y mRNA. 
For lesion-free skin, there was relative correlation for the endo-
thelial adhesion molecules and the PCR cytokine mRNA pattern . 
ELAM-1 and VCAM-1 were detected in three of five specimens and 
the same samples coexpressed TNF-O' and IL-1 mRNA. ICAM-l 
was .detected in three of five lesion-free samples and two of these 
specimens correlated WIth the expression of IFN-y. In the one le-
Table I. Correlation of Expression of Cytokine mRNA and Adhesion Molecules in Skin Biopsies. 
Lesional Skin (patient number) Lesion-Free Skin (patient number) Normal Skin (patient number) 
2 3 4a 4b 5 6 7 8 9 1a 1b 2 3 4 6 7 8a 8b 9 lOa lOb 11 12a 12b 12c 13 
IL-2 2 3 2 2 3 2 0 0 0 0 0 0 0 0 
IFN-y 1 1 1 1 3 0 0 0 2 2 0 0 0 0 [L-4 0 0 0 0 0 0 0 0 0 0 2 0 0 0 
11-10 2 2 0 0 0 0 0 0 1 0 1 0 0 1 
11-1 a 2 2 2 3 4 1 2 3 3 1 0 3 2 0 
11-1 P 3 3 3 3 3 3 1 2 2 1 1 1 0 0 
TNF-a 3 2 2 2 3 3 2 2 2 2 2 1 0 0 
GM-CSF 0 0 0 1 1 0 0 0 0 0 0 1 1 1 
ELAM-l 4 NOb 3 3 4 4 4 4 4 4 1 1 2 2 0 1 2 2 0 0 0 NO 0 1 0 0 
VCAM-l 3 NO 3 3 4 3 ' 2 3 3 3 2 0 3 3 0 0 1 2 1 0 0 NO 0 0 0 0 
ICAM-l 1 NO 2 2 2 2 2 2 2 1 2 0 2 2 0 0 0 0 0 0 0 NO 0 0 0 0 
• Biopsy samples were analyzed using PCR for expression of cytokines and immunostaining to detect adhesion molecules. Autoradiographic results were ranked 0- 4 based on band 
itmnsity (0- 100% of maximum) and immunostaining findings were scored 0-6 based on the number of positive cells. 
I NO, not done. 
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Figure 2. PCR analysis of cytokine mRNAs isolated from psoriatic les ions 
(patients 1,2,3, 4a, 4b, 5}, lesion-free psoriatic sk in (patients l a, Ib, 2, 3, 4) , 
and normal skin (patients lOa, lOb, 11). cDNA concentrations used for PCR 
were normalized to yield similar quantities of CD38 chain-amplified prod-
ucts to evaluate cytokines produced predominately by T cells. Samples were 
analyzed for expression ofIL-2, IFN-y, IL-4, and IL-I0 using cytokine-spe-
cific PCR oligonucleotide primers. PCR products were resolved by electro-
phoresis, transferred to nylon membranes, and probed with a labeled internal 
oligonucleotide. 
sion-free sampl e that had no ELAM- l , VCAM-l , or IC AM-l de-
tectable, the PCR revealed no detectable IFN-y or IL-la mRNA 
and only minimally detected mRNA for TNF-a and IL-1f/. These 
trends were refl ected in the normal skin biopsies, in w hich the 
absence of ELAM-1 , VCAM-1 , and ICAM-1 expression was ac-
companied by no detectable levels ofIFN-y mRNA and only weak 
T N F-a and IL-lf/ mRNA levels in one of three specimens. The 
more strongly detected IL- la mRNA levels in two of three normal 
specimens suggests that ;11 11 ;110 IL- l a may not be contributing to the 
induction of ELAM-1 and VC AM-1, or if it is being produced, its 
bio logic activity may be nullified by the co-presence of an IL-1 
inhibitor such as lL- l receptor antagonist protein. 
Finally, analyses of replicate biopsies from the same individuals 
revealed consistent patterns of cytokine and adhesion molecule ex-
pression. Elevated levels of type 1 cytokines, IL-1, and TNF-a 
m RNAs were detected in the two lesional biopsies from one patient 
w ith psoriasis (4a and 4b) . Similarly, lesion-free biopsies (1 a and 1 b) 
fro m another patient displayed internal consistency in the relative 
expression of cytokine and adhesion molecul es. Message for IL-1a, 
lL-lf/, and TNF-a were detected in replicate lesion-free biopsies. 
Comparable immunostaining resul ts for ELAM-1 were observed in 
these biopsies although VCAM-1 and ICAM-1 were detected in 
only one of the replicate specimens. These findin gs reflect the com-
parable reproducibility of the PC R and immunostaining techniques 
used in this study . 
DISCU SSION 
A complex series of cellular interactions coordinated by lymphocyte 
adhesion to a variety of cell types are involved in the induction and 
maintenance of psoriatic lesions [20] . Molecules that function to 
mediate such ad hesive events include ELAM-1 , VC AM-1 , and 
ICAM-1 [21] . It is likely that these adhesion molecules involved in 
the intraepiderma l traffickin g and local accumulation of inflamma-
tory cells are regulated by cytokines such as lFN-y and TNF-a. In 
this study, a comprehensive examination of the cytokine network as 
well as aberrant adhesion molecule express ion were performed on 
th ree differe nt sets of ti ssue samples incl uding lesional skin of psori-
atic patients, les ion-free skin of psoriatic patients, and normal skin 
of healthy donors. By combining a PCR-based analysis of cytokine 
mRNAs with immunostainin g to detect adhesion molecules on 
matched skin biopsies, we conclude the following: 1) ac tive psori-
atic plaques express a pattern of cytokines that best resembles a type 
1 profil e; 2) lesion-free skin of psoriatic patients is not entirely 
normal in that lFN -y, TNF-a, and lL-lf/ mRNAs were more 
strongly expressed compared to healthy control individuals; and 3) 
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there is an excellent correlation between the presence of various 
cytokine mRNAs w ith aberrant adhesion molecule expressio n. 
PCR analysis of psoriatic skin lesions displayed a "type 1" cyto-
kine pattern typified by increased expression of mRNA for IL-2, 
lFN-y, and lymphotoxin concurrent with a relative lack of " type 2" 
cytokines (i .e., lL-4, IL-5, and IL-10). T he type 1 cytokine pattern 
observed in these lesions resembl es those of murine T H 1 cells, char-
acteristic of cell-mediated immune responses to infectious patho-
gens and delayed-type hypersensitivity reactions [9,22]. In contrast, 
the " type 2" cytokine response is associated w ith humoral re-
sponses, susceptibility to infection, and all ergen- induced late-phase 
reactions. W e fo und that expression of type 1 cytokine mRNAs w as 
prominent in psoriatic lesions as well as in lesions of lichen planus, 
an inflammatoty dermatosis that shares wi th psorias is a postulated 
autoimmune etio logy [23,24] . Therefore, the data indicate that the 
pathogenesis of skin diseases in w hich autoimmune T cells may play 
a role, as well as other inflammatory disorders of skin, include the 
local production of type 1 cytokines. 
Similar to th e distinctive pattern of expression ofT -cell- derived 
cytokines, we found elevated expression of mRNA for IL-1P and 
TNF-a in psoriatic versus normal skin. IL-l is of particular interest 
in psoriasis because of its crucial role in initiating T-cell activation, 
its function as a chemotactic fac tor fo r T -cells, and its direct induc-
tion of keratinocyte and fibroblas t pro liferation [25,26]. TNF-a , 
expressed by dermal dendrocytes, has been reported to induce pro-
liferation of keratinocytes as well as induce express ion of adhesion 
molecules [1 6]. H owever, we found little di ffe rential expression of 
mRNA for IL-1a in psoriatic compared to 110rmal skin. Indeed 
previous studies have demonstrated profound reduction in IL- 1a 
activity and increase in non-functionaIIL-lp in psoriatic epidermis 
compared to normal skin [27]. Thus the exact role of this rnonokine 
remains to be determined. 
An important objective of our study was to assess the immuno-
logic status of lesion-free skin of psoriatic patients by examining the 
cytokine profil e of clin.icaJly symptomless skin in individuals with 
psoriasis. Interestingly, we found lesion-free skin, similar to psori-
atic lesions, to show elevated express ion of lFN-y, IL-1f/, and T NF-
a mRNAs compared to normal skin of contro l subjects. The finding 
of aberrant levels of cytokine expression in lesion-free skin suggests 
that immunologic alterations precede clinical manifestations of 
psoriasis. The aberrant expression of IFN-y, IL-f/, and TNF-a in 
both lesional and lesion-free skin indicates that these cytokines rna ' 
play a significant role in the pathogenic mechanism of psoriasis . 
Consistent with th e findin g of increased expression of lL-1jJ, 
TNF-a, and IFN-y in lesions of psoriasis was the observation of 
strong and diffuse expression of ELAM-1 and VCAM-1 by endo-












Figure 3. PCR analysis of cytokine mRNAs isolated froll1 psoriatic lesioru 
(patients 1, 2, 3, 4a, 4b, 5) , lesion-free skin (patients la, Ib, 2, 3, 4) , and 
normal skin (patients lOa, lOb, 11). Initially, cDNA quantities were nor-
malized for total cell number to yield similar quantities of p-actin amplified 
products. PCRs were performed using oligonucleotide primers for IL-lo, 
IL-1P, TNF-a, and GM-CSF. Ampl ified products were resolved by electro-
phores is, transferred to nylon membranes, and probed with a labeled internal 
oligonucleotide. Autorad iographic findings are presented. 
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helial cells, and ICAM-1 by keratinocytes. III active psoriatic 
t laques, there was strong and diffuse expression of ELAM-1 and 
VCAM-l by endothelial cells, and ICAM-1 by keratinocytes: Fur-
thermore, the absence of. aberrant adhesion molecule expressIOn m 
normal skin correlated with the lack of detectIOn of either IFN-y or 
TNF-a. In lesion-free skin, the presence and extent of aberrant 
adhesion molecule expression paralleled most closely the presence 
f TNF-a mRNA. This is not completely unexpected because 
~NF-a is the only known cytokine that can simultaneously uIJ-
egulate endothel ial cell ELAM-l and VCAM-l, as well as keratl-
~ocyte ICAM-1 [16]. Such clear-cut correl~tion as obs.erved for 
IFN-Y and TNF-o: with respect to the 1I1duc~lOn of adhesion mole-
cules was not seen for IL-l in theg:oups of Sk111 sampled, suggest111g 
hat IL-l inhibitors may be partlClpat111g 111 cutaneous l1nmunoho-~eostasis. Previous investigators have noted discrepanci~s between 
IL-l mRNA levels and functional protein [27]. lnterleukm-l recep-
tor antagonist protein has been detected 111 psonatlc sk1l1, wh ich 
robably explains these discrepancies [281: . . ., 
p The pathophysiologic aspect of our find111gs 111c1udes c1l111call111-
lications. There is a growing interest in the role ofT lymphocytes 
P psoriasis based on the therapeutic efficacy of cyclosponne and 
:ti-CD3 monoclonal antibody therapy [5,29]' The current re~ults 
support the local cutaneous production .of several T-cell-denved 
cytokines wlth111 psor.latlc leSIOns, 111c1udl~1~ IF~-y and IL-2. I~N-y 
may be particularly Imp.ortant because 111~ectlOn of r~C?mb111ant 
IFN -y into lesion-free Sk111 can 111duce a leSion that IS c1.lI11callyand 
histo logically indistinguishable from idiopathic 'ps~natlc lesIOns 
[30]. That psoriasis is a type 1 cytok111e response 111dlcated by ele-
ated levels of IL-2 mRNA in lesional and lesion-free Sk111 may ~xplain the exacerbation noted following IL-2 immunotherapy [31] 
and suggest the possible efficacy ofIL-2 antag0111sts m the treatment 
of psoriasis. Also, the lack of type 2 cytokl11es such as IL-4 and IL~ 10 
suggests that it may be possible to tre~t p~onaSlS by admllus~enng 
hese cytokines or their analogues to mhlblt further expansIOn of 
t d . this cell-mediate immune reactIOn. . ' 
In the present study, we have hn~edmolecular and l1nm~noh~s­
cologie approa~hes t.o ach~eve new mSlghts 111to the cytob~e-dlr­
cted response 111 active leSIOns and leSIOn-free Sk111 of psonasls. Our 
findings provide additional itl vivo-denved data t~lat support the 
rowing recognition that discrete profiles of cytokmes a~d specific ~dhesion molecules display important pat~ophyslOlog lc mecha-
nisms in human disease. Future studies that mvestlgat.e the factors 
responsible for this type 1 cel l cytokine response are hkely to IJro-
vide a greater understanding of the pathophysIOlogy of psonasls. 
We are graujit! 10 Dr. Shllzhllallg LIIJor leclwical experlise alld 10 Diane Reisillger 
for help in desigllillg some oflhe cylokille primers alld probes. We thauk Thomas H. 
Rea Jor providillg leprosy skill specimells . We also Ilwllk Kev", Moore Jar the 
getlerous gift oj IL-l 0 primers alld probe. 
supported by gra II (s from the Natiollalltlstillltes oJHealth AI22553, AR40312 
(RIM); AR31957, AR40065, AR01823 (BJ~); the S~sak~lVa Memorial 
FOUNdation; and Ih e Dermalology Research FOlI/ldallOIl oj Califonlla. 
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